Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SHR-1209 in Hypercholesterolemia and Hyperlipidemia
CTR20210703Phase 3Completed
- Sponsor
- Suzhou Sundia Biotech Co., Ltd.
- Start
- Apr 2021
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
A Phase 3 trial of recaticimab in hypercholesterolemia, hyperlipidemia, sponsored by Suzhou Sundia Biotech Co., Ltd.. Started Apr 2021; status: completed.
02
Drugs
recaticimab
03
Conditions
hypercholesterolemiahyperlipidemia
Beyond the preview
Go deeper on CTR20210703.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20210703.